SELONTERRA
Selonterra is a biopharmaceutical company that works on Alzheimer's and Parkinson's disease therapies and diagnostics. The company is based in the San Francisco Bay Area that is backed by venture capital.
SELONTERRA
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2017-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.selonterra.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
PHP Yahoo Image CDN
Similar Organizations
Peptinovo Biopharma
Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.
Current Employees Featured
Founder
Official Site Inspections
http://www.selonterra.com Semrush global rank: 4.03 M Semrush visits lastest month: 3.05 K
- Host name: cpanel278.turbify.biz
- IP address: 34.206.33.213
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Selonterra"
About Us - Selonterra
Prior to founding Selonterra, she was the sole- proprietor of Migraine Therapeutics. Her project was awarded by a commission of experts from the Biovalley Life Sciences Network …See details»
Selonterra - Crunchbase Company Profile & Funding
Organization. Selonterra . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ...See details»
Selonterra, Inc. - LinkedIn
Selonterra, Inc. is a San Francisco Bay Area venture capital funded Delaware corporation. Selonterra fundamentally transforms therapeutic approaches to neurodegenerative disorders, …See details»
Overview - Selonterra
The Selonterra Platform. Effective Drugs. Development of orally available, disease modifying therapies. Drug Development. Small molecule discovery program. Disease Pathway. …See details»
Selonterra Company Profile | Management and Employees List
Selonterra Profile and History . Selonterra was founded in 2008 to identify novel therapeutics and diagnostics for neurodegenerative disorders. Our focus is on Alzheimer's disease, Parkinson's …See details»
Selonterra Company Profile 2025: Valuation, Funding & Investors
Selonterra General Information Description. Developer of novel therapeutics designed to address the unmet medical needs of Alzheimer's and Parkinson's patients. The company's …See details»
Selonterra Company Profile - Office Locations, Competitors ... - Craft
Selonterra has 5 employees at their 1 location. See insights on Selonterra including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
SELONTERRA LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SELONTERRA LLC of Belmont, CA. Get the latest business insights from Dun & Bradstreet.See details»
Selonterra - Overview, News & Similar companies | ZoomInfo.com
Mar 7, 2023 Selonterra Awarded US$2,500,000 Grant from The Michael J. Fox Foundation for Parkinson's Research SAN MATEO, Calif., March 8, 2023 /PRNewswire/ -- Selonterra, Inc. …See details»
Selonterra - Funding, Financials, Valuation & Investors - Crunchbase
Selonterra is a biopharmaceutical company that works on Alzheimer's and Parkinson's disease therapies and diagnostics. Search Crunchbase. Start Free Trial . ... How much funding has …See details»
Selonterra - Products, Competitors, Financials, Employees, …
Selonterra Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Research. Oct 8, 2024. Fox Foundation for Parkinson's Research USA - English Share this article Share …See details»
Selonterra and Axxam Enter into Drug Discovery Collaboration
Selonterra built a global network of specialized collaborator companies and applies state-of-the art technologies. For more information, please visit www.selonterra.com. ... Axxam S.p.A. is a …See details»
Selonterra - VentureRadar
Selonterra VentureRadar profile. Find out more about Selonterra, Small Molecule Pharmaceuticals.See details»
Selonterra - Contacts, Employees, Board Members, Advisors
Selonterra is a biopharmaceutical company that works on Alzheimer's and Parkinson's disease therapies and diagnostics.See details»
Selonterra Awarded Second Grant from The Michael J. Fox …
Oct 8, 2024 Selonterra, Inc. (www.selonterra.com), a biotechnology company developing transformative therapies for neurodegenerative disorders announces a second grant award of …See details»
Selonterra Awarded Second Grant from The Michael J. Fox …
SAN MATEO, Calif., Oct. 8, 2024 /PRNewswire/ -- Selonterra, Inc. (www.selonterra.com), a biotechnology company developing transformative therapies for neurodegenerative disorders …See details»
Selonterra Awarded US$2,500,000 Grant from The Michael J. Fox ...
Mar 8, 2023 Selonterra, Inc. (www.selonterra.com), a biotechnology company developing transformative therapies for neurodegenerative disorders announces a grant award of …See details»
MJFF awards Selonterra $2.5M more for Parkinson's research
Oct 11, 2024 Selonterra specifically will be testing whether compounds that increase the activity of Parkin, a protein linked to familial cases of Parkinson’s, can improve cognition and help …See details»
Selonterra awarded $2.5M for Parkinson’s genetics therapies
Mar 9, 2023 Selonterra is developing small molecules that can normalize the activity of these nearby genes, which may provide new pathways for treating Parkinson’s. The MJFF funding …See details»